home / stock / jspr / jspr articles

JSPR Articles, Jasper Therapeutics Inc. - From 03/21/24

Stock Information
Company Name: Jasper Therapeutics Inc.
Stock Symbol: JSPR
Market: NASDAQ
Website: jaspertherapeutics.com
Menu
JSPR JSPR Quote JSPR Short JSPR News JSPR Articles JSPR Message Board
Get JSPR Alerts

News, Short Squeeze, Breakout and More Instantly...
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference | Benzinga

REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on de...
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference | Benzinga

REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on dev...

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting | Benzinga

REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on dev...

Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying | Benzinga

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence ...
Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference | Benzinga

REDWOOD CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on dev...

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter r...

Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting | Benzinga

REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on dev...
Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences | Benzinga

REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on the...

Jasper Therapeutics Announces Oral Presentation of Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant at ASH 2023 | Benzinga

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on the...

Jasper Therapeutics Chief Financial Officer Awarded $357K Worth of Stock Options | Benzinga

Herb Cross, Chief Financial Officer at Jasper Therapeutics (NASDAQ:JSPR), reported a large acquisition of company stock options on September 26, ac...
Previous 10 Next 10